# Integrated Traditional Chinese and Clinical Medicine for Chronic Hepatitis B and Its Complication

> **NCT05128305** · PHASE3 · UNKNOWN · sponsor: **Qianfoshan Hospital** · enrollment: 276 (estimated)

## Conditions studied

- Hepatic Encephalopathy
- Cirrhosis, Liver
- Portosystemic Shunt

## Interventions

- **DRUG:** traditional Chinese medicine1 and traditional Chinese medicine 2

## Key facts

- **NCT ID:** NCT05128305
- **Lead sponsor:** Qianfoshan Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-12-01
- **Primary completion:** 2022-06-30
- **Final completion:** 2022-12-30
- **Target enrollment:** 276 (ESTIMATED)
- **Last updated:** 2021-11-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05128305

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05128305, "Integrated Traditional Chinese and Clinical Medicine for Chronic Hepatitis B and Its Complication". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05128305. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*